Detalhe da pesquisa
1.
Pharmacodynamic modelling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders.
Br J Clin Pharmacol
; 88(8): 3803-3812, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35332558
2.
A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults.
Antimicrob Agents Chemother
; 57(12): 6147-53, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24080653